NWPF

News Archives

Filtered by: June 2005

Stories needed to aid Parkinson’s research

Thursday June 30, 2005

Your story could be the key to finding a cure. The "Don’t Be Silent: Tell Us Your Story" initiative is the first nationwide effort to compile data on Parkinson’s disease from people who have the disorder, which affects the central nervous system.

Read Aricle

Parkinson’s patient participation needed

Thursday June 30, 2005

"Less than 1 percent of people with Parkinson’s are currently participating in clinical research," said Ben Kirby, communications director of the Parkinson’s Action Network. "That’s just not enough; we need more people to get involved."

Read Aricle

New Movement in Parkinson’s

Thursday June 30, 2005

Parkinson’s disease, first described in the early 1800s by British physician James Parkinson as "shaking palsy," is among the most prevalent neurological disorders.

Read Aricle

Michael J. Fox and Parkinson’s Disease

Thursday June 30, 2005

Between one and one-and-a-half million Americans are affected by Parkinson’s disease, a disorder of the central nervous system. "Parkinson’s" is the overall term for at least six different categoriesof the disorder, which usually affects people age 50 or older.

Read Aricle

Teva and Lundbeck Announce That Azilect (Rasagiline) for Parkinson’s Disease is Now Available in the United Kingdom; Additi

Thursday June 30, 2005

Teva Pharmaceutical Industries Ltd. (Teva) (NASDAQ: TEVA) and H. Lundbeck A/S (Lundbeck) (CSE: LUN) announced today that Azilect(R), a once-daily treatment for Parkinson’s disease (PD) both as monotherapy in patients with early PD and as an adjunct treatment in moderate to advanced disease, is now available in the United Kingdom.

Read Aricle

Living Large With Parkinson’s

Thursday June 23, 2005

When I was diagnosed with Parkinson’s disease, I had little knowledge of what lay ahead. Most people share that ignorance. Though the reactions of the few I told about my condition were typically intense, with exclamations of great pity or sorrow, this was often followed by a very honest "What exactly is Parkinson’s?"

Read Aricle

Majority of Physicians Who Treat Parkinson’s Do Not Refer Patients to Clinical Trials, According to National Survey

Thursday June 23, 2005

While almost all (more than 96 percent) of the physicians (i) in the United States who treat people with Parkinson’s agree that clinical trials are necessary to find better treatments for the disease, the majority of physicians have discussed clinical trials with just 10 percent or less of their patients with Parkinson’s disease (65 percent of neurologists and 54 percent of primary care physicians/gerontologists) and have never referred a patient to a clinical trial (53 percent of neurologists and 83 percent of primary care physicians /gerontologists). These are among the highlights of a recent nationwide survey commissioned by The Michael J. Fox Foundation for Parkinson’s Research and conducted by Harris Interactive(R) on behalf of the Advancing Parkinson’s Therapies (APT) campaign.

Read Aricle

Faulty enzyme sparks Parkinson’s disease

Thursday June 23, 2005

Parkinson’s disease is caused by a faulty enzyme that causes brain proteins to clump -- much like Alzheimer’s or Huntington’s disease, Texas researchers say.

Read Aricle

Stem cell pioneer does a reality check

Thursday June 23, 2005

In a wide-ranging interview, the man who first cultured human embryonic stem cells talks about the science and the morality surrounding his research.

Read Aricle

Parkinson Association of the Carolinas Event Schedule

Wednesday June 22, 2005

This summer, the Parkinson’s Association of the Carolinas will be hosting many educational symposia. Here is a schedule of events and a list of the speakers and topics.

Read Aricle
<< Back 1 - 10 of 37 Next >>